Literature DB >> 3280674

The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents.

J Conway1, J Johnston, A Coats, V Somers, P Sleight.   

Abstract

A low-cost ambulatory blood pressure measuring device has been developed from a commercially available stationary apparatus. The device, which has been compared for accuracy with a mercury manometer, has functioned satisfactorily as an ambulatory monitor for 4 years. To minimize errors, blood pressure readings were made in the sitting position at half-hourly intervals over the waking day. The utility of the device in clinical trials has been investigated. On repeated readings no placebo effect on blood pressure was detectable and the mean difference between two readings in 42 subjects was 1.9/-0.33 mmHg. The standard deviation of the difference were 8.1/5.6 mmHg. This should make it possible to detect differences of 8/5 mmHg between two treatments in about 16 subjects. There was no detectable tendency for blood pressure to change during the day but the variability between readings was substantially increased if the observation periods were reduced to 4 h.

Mesh:

Substances:

Year:  1988        PMID: 3280674

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  19 in total

Review 1.  Importance of various methods of blood pressure measurement in clinical trials.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 2.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

3.  Systemic and forearm vascular resistance changes after upright bicycle exercise in man.

Authors:  A J Coats; J Conway; J E Isea; G Pannarale; P Sleight; V K Somers
Journal:  J Physiol       Date:  1989-06       Impact factor: 5.182

Review 4.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

5.  Ambulatory pressure monitoring in the assessment of antihypertensive therapy.

Authors:  A J Coats; J Conway; V K Somers; J E Isea; P Sleight
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 6.  The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events.

Authors:  Josep Redon
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27

7.  Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.

Authors:  D Maclean; E T Mitchell; E M Laing; F C Macdonald; K J Gough; R J Dow; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

8.  Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly.

Authors:  P Campbell; N Ghuman; D Wakefield; L Wolfson; W B White
Journal:  J Hum Hypertens       Date:  2010-03-04       Impact factor: 3.012

9.  Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.

Authors:  A G Dupont; J M Coupez; P Jensen; R Coupez-Lopinot; D F Schoors; P Hermanns; M Nicolas
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

10.  Nicardipine sustained release in hypertension.

Authors:  J Webster; J C Petrie; T A Jeffers; P Roy-Chaudhury; W Crichton; K Witte; M Jamieson; F C MacDonald; M Beard; R J Dow
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.